Recently, a considerable attention emphasis is on novel role (TP53) in developing cancer, in pathways related to metabolic traits such as obesity, insulin sensivity, inflammation of adipose tissue, and homeostasis of skeletal muscle [12, 13]. Here, TP53 is linked to cancer.